Survisc®Plus
by Shanghai Qisheng Biological Preparation Co., Ltd 4 variants
Ref 20mg/mL-0.4mLModel Survisc®, Survisc®Plus
Active
CE MDR
Valid until
Not listed
FDA recalls
Not applicable
Documents
None linked in EUDAMED
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/MDR | Number69318611ophtha0012H | Date12 Dec 2025 | StatusActive |
Certificates
EUDAMED lists no certificate for this device's Basic UDI-DI.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
European Union — CE/MDR Active
Specification
- Device Name
- Sterile Medical Sodium Hyaluronate
- Model / Reference
- Survisc®, Survisc®Plus, 20mg/mL-0.4mL
- Primary DI / UDI-DI
- 06931861100377, 06931861105143
- Basic UDI-DI
- 69318611ophtha0012H, 69318611ophtha0022K
- EMDN Code
- Q02030301 Ophthalmology, hyaluronic acid and derivatives
- Device Class
- Class IIa
- EU market of registration
- France
- Medical Purpose
- SURVISC is indicated for using as a surgical aid in ophthalmic anterior segment surgery including cataract extraction, lens implantation and corneal transplantation surgery and glaucoma filtering surgery.
Manufacturer details
- EUDAMED SRN
- CN-MF-000023601
- Authorised representative
- Medical Technology Promedt Consulting GmbH DE-AR-000000085
Other devices from Shanghai Qisheng Biological Preparation Co., Ltd
See all devices from Shanghai Qisheng Biological Preparation Co., Ltd →
Properties
Other properties (12)
- Implantable: No
- Reusable: No
- Contains Latex: No
- Reprocessed: No
- CMR Substance: No
- Human-derived: No
- Human Tissues: No
- Animal Tissues: No
- Endocrine Disruptor: No
- Administering Medicine: No
- Measuring Function: No
- Incorporates Medicinal Product: No